U.S. markets closed

  • S&P Futures

    3,981.25
    +3.25 (+0.08%)
     

  • Dow Futures

    32,340.00
    +21.00 (+0.06%)
     

  • Nasdaq Futures

    12,856.25
    +2.25 (+0.02%)
     

  • Russell 2000 Futures

    1,738.00
    +5.50 (+0.32%)
     

  • Crude Oil

    69.46
    -0.50 (-0.71%)
     

  • Gold

    1,993.20
    -2.70 (-0.14%)
     

  • Silver

    23.16
    -0.10 (-0.41%)
     

  • EUR/USD

    1.0833
    -0.0004 (-0.03%)
     

  • 10-Yr Bond

    3.4060
    -0.0940 (-2.69%)
     

  • Vix

    22.61
    +0.35 (+1.57%)
     

  • GBP/USD

    1.2274
    -0.0014 (-0.12%)
     

  • USD/JPY

    130.7690
    -0.0200 (-0.02%)
     

  • Bitcoin USD

    28,349.32
    +1,007.06 (+3.68%)
     

  • CMC Crypto 200

    619.70
    +22.24 (+3.72%)
     

  • FTSE 100

    7,499.60
    -67.24 (-0.89%)
     

  • Nikkei 225

    27,419.61
    0.00 (0.00%)
     

Industrial Microbiology Market Report (2022 to 2030) - The 3M Company, Danaher Corporation, Thermo Fisher Scientific, QIAGEN, Bio-Rad Laboratories Inc.

Growth Plus Reports
·5 min read
Growth Plus Reports
Growth Plus Reports

Pune, Nov. 30, 2022 (GLOBE NEWSWIRE) -- According to a new market research report titled, “Industrial Microbiology Market by Product (Instrument and System and Consumables), by Application (Pharmaceutical & Biotechnological Industries, Food & Beverage Industries, Agriculture & Environmental Industries, Cosmetics & Personal Care Industries and Others), by Test Type (Sterility Testing, Microbial Limit Detection, Bio-burden Detection Testing, Environment Testing and Others), by End User (Academic & Research Institutes, Pharmaceutical & Biotechnological Companies, Hospitals & Clinical Diagnostic Centres, Others) – Global Outlook & Forecast 2022-2030 " published by Growth Plus Reports, the Industrial Microbiology Market is expected to grow at a CAGR of 7% from 2021 to reach US$ 122 billion by 2030.

Click Here to Get a Sample Copy: -
https://growthplusreports.com/inquiry/request-sample/industrial-microbiology-market/7944

Market Drivers

The introduction of new, cutting-edge products that can enhance or improve industrial microbiology operations is one of the main reasons that are anticipated to have a positive impact on the market for industrial microbiology. June 2022, STEMart introduced thorough sterility and microbiological testing services for sterile, non-pyrogenic products. Additionally, KTA Nutrition and Sundyota Numandis Group collaborated to introduce a range of nutraceutical products in India in December 2021 using high-quality ingredients. Products available include Beet Strong, Good Immunity, and Bye-Bye Stress, which support the body's natural ability to fight infections and encourage relaxation and sleep (which promotes overall well-being with added benefits of beetroot).

Excerpts from ‘By Application Segmentation’

Based on application, the global industrial microbiology market has been segmented into

  • Pharmaceutical & Biotechnological Industries

  • Food & Beverage Industries

  • Agriculture & Environmental Industries

  • Cosmetics & Personal Care Industries

  • Others

Over the course of the forecast period, the pharmaceutical and biotechnology industry segment is anticipated to experience significant market growth as a result of factors like rising R&D expenditures and the production of life-saving medications and therapies, particularly in the case of antibiotics and other antimicrobials. The role of microbiology in the pharmaceutical and biotechnology industry is anticipated to expand along with the rising demand for medications and treatments globally, which is anticipated to promote expansion in the research segment. Moreover, it is anticipated that the pharmaceutical and biotechnology industries in the market under consideration would increase primarily as a result of the rising research and development spending by pharmaceutical and biotechnology firms around the world. For instance, the Congressional Budget Office reported that, in June 2021, the pharmaceutical industry worldwide spent close to USD 200 billion on research and development, compared to USD 83 million in 2019. Becton, Dickinson, and Company also spent USD 1,339 million more on research and development in FY2021 than in FY2020 ($1,096 million).

Excerpts from ‘By Region Segmentation’

Based on product, the global industrial microbiology market has been segmented into

  • North America

  • Europe

  • Asia Pacific

  • Rest Of The World

The North America dominated the market during forecast period due to significant share over the forecast period due to a significant investment made in the research and development of new products by the pharmaceutical, biotechnology, and food industries, as well as an increase in product launches and a rise in the demand for fermented foods and nutraceuticals in the region. For instance, the Canadian pharmaceutical industry spent between USD 1.5 and USD 4.0 billion on research and development in 2019, with USD 2 billion going toward internal research and USD 950 million going toward both domestic and international research and development outsourcing, according to Statistics Canada's May 2021 report. The North American region is thus anticipated to hold a sizable position in the studied market over the course of the study's prediction period as a result of the aforementioned variables.

Excerpts from ‘Competitive Landscape’

Some of the Prominent market players in the global industrial microbiology include,

  • The 3m Company

  • Danaher Corporation

  • Thermo Fisher Scientific

  • Eppendorf Ag

  • Asiagel Corporation

  • Sartorius Ag

  • Bio-Rad Laboratories Inc.

  • Becton

  • Dickinson Company

  • Merck Kgaa

  • Novamed Ltd.

  • Biomérieux Sa

  • Qiagen

Due to the presence of several companies in different geographic regions, the industrial microbiology market is fairly competitive. By providing the newest goods available, these businesses help various industries expand both domestically and internationally.

Inquire Before Buying This Research Report:

https://growthplusreports.com/inquiry/before-buying/industrial-microbiology-market/7944

Table of Content

  1. INTRODUCTION

    1. Market Ecosystem

    2. Timeline Under Consideration

      1. Historical Years - 2020

      2. Base Years - 2021

      3. Forecasted Years – 2022 to 2030

    3. Currency Used in the Report

  2. RESEARCH METHODOLOGY 

    1. Research Approach

    2. Data Collection Methodology

    3. Data Sources

      1. Secondary Sources

      2. Primary Sources

    4. Market Estimation Approach

      1. Bottom Up

      2. Top Down

    5. Market Forecasting Model

    6. Limitations and Assumptions       

  3. PREMIUM INSIGHTS

    1. Current Market Trend (COVID-19 Perspective)

    2. Key Players & Competitive Positioning (2021)

  4. MARKET DYNAMICS

    1. Drivers

    2. Restraints/Challenges

    3. Opportunities

  5. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET - ANALYSIS & FORECAST, BY PRODUCT

    1. Instrument and System

    2. Consumables

  6. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET - ANALYSIS & FORECAST, BY APPLICATION 

    1. Pharmaceutical & Biotechnological Industries

    2. Food & Beverage Industries

    3. Agriculture & Environmental Industries

    4. Cosmetics & Personal Care Industries

    5. Others

  7. GLOBAL INDUSTRIAL MICROBIOLOGY MARKET - ANALYSIS & FORECAST, BY TEST TYPE

    1. Sterility Testing

    2. Microbial Limit Detection

    3. Bio-burden Detection Testing

    4. Environment Testing

    5. Others

TOC Continue…

Scope of the Report:

Report Attribute

Details

Market size value in 2021

US$ 66.5 billion

Revenue forecast in 2030

US$ 122 billion

Growth Rate

CAGR of 7% from 2022 to 2030

Base year for estimation

2021

Forecast period

2022-2030

Segments covered

by product, application, test type, end user and region.

Regional scope

North America, Europe, Asia Pacific, and the Rest of the World (ROW)

VALUE PROPOSITIONS RELATED TO THE REPORT:

  • Powered with Complimentary Analyst Hours and Expert Interviews with Each Report

  • Comprehensive quantitative and qualitative insights at segment and sub-segment level

  • Covid 19 impact trends and perspective

  • Granular insights at global/regional/country level

  • Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment

  • Blanket coverage on competitive landscape

  • Winning imperatives

  • Exhaustive coverage on 'Strategic Developments' registered by leading players of the market

CUSTOMIZATION OPTIONS:

  • Distributor Landscape Assessment

  • Pipeline Assessment

  • Pricing Intelligence

  • Customer Base Assessment

  • Investment & Initiatives Analysis

  • 'Business Profile' of Key Players

Quickly Purchase Premium Copy of Industrial Microbiology Market Report:

https://growthplusreports.com/checkout?_token=ZBFN3ej56wfAEWYYey164hgggg4oKKCPymhLP1xl&report_id=7944&license=Single

About Us        

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis, and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

CONTACT: Manan Sethi Director, Market Insights Email: enquire@growthplusreports.com Phone no: +91 96545 76783 Web: https://growthplusreports.com/


Recommended Stories

  • Think Texas has a cheaper tax burden than California? Think again.

    "When people are like, 'Oh California is so much more expensive than Texas,' that’s the top income tax rate."

  • 'It's a b----, but you gotta do it': Charlie Munger says that your first $100K is the toughest to earn — but most crucial for building wealth. Here's why it's such a magical milestone

    Here's why 100K is a magic financial milestone.

  • No 'Guarantee' But Yellen May Have Just Set a Trap for the Bears

    For once, Wall Street isn't blaming Powell for a market beatdown. Here's how I expect things to play out as we edge toward the end of March.

  • Bill Ackman warns US economy headed for 'train wreck' after latest Fed rate hike

    Hedge fund manager Bill Ackman sounds the alarm on the state of the U.S. economy amid a banking crisis and the Federal Reserve's fight against inflation.

  • The Average 401(k) Balance by Age: Are You Off the Mark?

    It can be hard to know if your retirement savings are on track, but comparing your balance to where others similar in age are can help. In particular, taking a look at the average 401(k) balance by age is a good place … Continue reading → The post The Average 401(k) Balance by Age: Are You Off the Mark? appeared first on SmartAsset Blog.

  • ‘Our Best Long-Term Picks’: Morgan Stanley Suggests 3 High-Quality Stocks to Buy Now

    Stock experts often tout the merit of taking the long-term view rather than looking for short term gains. It’s a strategy that gets the thumbs up from Morgan Stanley’s US Equity Strategy team, led by Mike Wilson. Wilson has been one of the Street’s most vocal bears for a while, but while he does not see the bear market as over just yet, he forecasts a “stronger earnings picture” by next year. A friendlier monetary policy, high inflation receding, pent-up demand in investment/capex and in specifi

  • Down More Than 50%: 2 ‘Strong Buy’ Stocks That Are Too Cheap to Ignore

    When stock prices fall, opportunities open up. That’s true whether we’re talking about a general market decline, or a slip in some individual stocks. However, it is crucial for investors to conduct due diligence and investigate the reasons behind the drop in price to ensure that they are making informed investment decisions. The key to success here is recognizing when a low-priced stock is fundamentally unsound or just facing tough trading conditions. Fortunately, Wall Street’s equity analysts a

  • Block stock falls 15% amid short seller accusations of 'inflated metrics' and avoiding regulation

    Block stock fell 15% after short seller Hindenburg Research said the digital payment company formally known as Square has "systematically taken advantage of the demographics it claims to be helping."

  • Charles Schwab Says It Could Ride Out a Deposit Flight

    Charles Schwab , one of a host of financial firms that have taken a drubbing since the collapse of several regional banks this month, is pushing back against fears that it could face some of the same problems as paper losses on its bondholdings mount. In an interview with The Wall Street Journal, Schwab’s chief executive said the brokerage giant could continue to operate even if it lost most of its deposits over the next year. “There would be a sufficient amount of liquidity right there to cover if 100% of our bank’s deposits ran off,” said Walt Bettinger, Schwab’s co-chairman and CEO, referring to the company’s banking unit.

  • Cathie Wood Suffers Double Blow as Drama Hits Coinbase and Block

    (Bloomberg) -- An activist short seller attack on one US firm and the threat of regulatory action against another have conspired to deal a double blow to Cathie Wood and ARK Investment Management, as both shares are among her top holdings.Most Read from BloombergJack Dorsey’s Block Vows to Fight Back After Hindenburg Says It’s Short the StockShort Seller Hindenburg Says ‘Another Big One’ Coming SoonUS Fears a War-Weary World May Embrace China’s Ukraine Peace BidJPMorgan Sold $10 Million in Jewel

  • Real estate billionaire Sam Zell warns that hot inflation isn't going away anytime soon, says the Fed 'screwed up' — here are 3 real assets to help protect your wealth

    Disinflation might be a pipe dream.

  • Regeneron Breaks Out On Home Run In 'Smoker's Lung' As Sanofi Soars

    Sanofi and Regeneron's asthma drug Dupixent succeeded in a study of patients with "smoker's lung," leading SNY and REGN stocks to rocket.

  • ‘Gerbil banking’ preceded the Great Depression. We’re seeing it again today

    Big banks are attracting more deposits–and putting money back into failing banks. A similar system existed in the run-up to the Great Depression.

  • Realty Income Pays a 5.1% Dividend Yield; Here's When to Buy the Dip

    Realty Income, stock symbol O, is one of the most consistent dividend payers in the markets. Here's when and where to buy the dip.

  • Leaked Documents Show Amazon Made an Enormous Mistake

    The last year has seen a large number of job layoffs in the technology sector. Major companies like Salesforce, ESPN, Microsoft, Google, and Meta Platforms have all announced cuts to staffing -- a move that has been largely attributed to the rapid growth of online tech during the covid-19 lockdown. Amazon is one of the biggest companies announcing waves of job cuts -- in January, the company let go of more than 2,300 employees in the payments, health care, human resources, robotics, and web services departments.

  • Short Seller Hindenburg Says ‘Another Big One’ Coming Soon

    (Bloomberg) -- Hindenburg Research said it will soon release a new report, two months after the US short seller’s explosive allegations against Adani Group wiped more than $100 billion off the Indian conglomerate’s market value.Most Read from BloombergJack Dorsey’s Block Vows to Fight Back After Hindenburg Says It’s Short the StockShort Seller Hindenburg Says ‘Another Big One’ Coming SoonUS Fears a War-Weary World May Embrace China’s Ukraine Peace BidFinally, a Serious Offer to Take Putin Off Ru

  • George Soros and Steve Cohen Have One Thing in Common: They Both Bet on These 2 Stocks

    In this uncertain market environment, the educated investor would do well to seek out some signal that can cut through the noise and indicate the sound stock purchase choices. Following the legendary investors, the traders who build multi-billion dollar fortunes on the stock market trading scene, is a popular strategy – and when two of those investing legends agree… well, there’s a stock that should definitely get a second look. George Soros and Steve Cohen have both built fortunes, for themselv

  • Is $5 Million Enough to Retire at 65?

    Retirement planning has many elements, but there are two questions that must be answered before anything else can be addressed: What age do you plan on retiring? And, how much money do you need saved to retire at that age? … Continue reading → The post Is $5 Million Enough to Retire at 65? appeared first on SmartAsset Blog.

  • ‘Load Up,’ Says Raymond James About These 3 ‘Strong Buy’ Stocks

    The last few weeks have been rocky, with the collapse of Silicon Valley Bank, and the crypto-heavy Silvergate and Signature banks, dominating the headlines. For a short time, it seemed that the contagion would spread to the global financial giants. Now, however, it appears that we’ve managed to avoid a true banking crisis – and Raymond James’ chief investment officer Larry Adam has pointed out several reasons why. For starters, Adam notes that Credit Suisse, despite its troubles, found a way out

  • Ford’s Model E Segment Means Something For Rivian. It Isn’t Good.

    Ford Motor is letting investors peek under the hood of the electric-vehicle startup the 119-year-old company is building. Ford (ticker: F) said it “refounded” on Thursday. Ford also released recast financial results for the three business units.